Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xicheng Yang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatmentSichen Yuan, Xicheng Yang, Alexa M Bremmer, et al.
Mediators of Inflammation|September 2, 2022
Exosome in Crosstalk between Inflammation and Angiogenesis: A Potential Therapeutic Strategy for StrokeYongdan Cun, Yaju Jin, Danli Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2018
Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomibYulong Xu, Xicheng Yang, Yiyi Chen, et al.
Nature Nanotechnology|May 16, 2025
Engineering pyroptotic vesicles as personalized cancer vaccinesZhaoting Li, Yixin Wang, Fanyi Mo, et al.
European Journal of Medicinal Chemistry|October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activitiesXicheng Yang, Jian Shen, Lulu Jiang, et al.
Nature Communications|December 12, 2025
Dynamically tunable polarized mid-infrared light-emitting diodes from polarization singularities in a band-edge Weyl nodeJunrong Zhang, Fengyuan Xuan, Jiexi Song, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address ConceptLi Xiao, Yujun Wang, Mumei Zhang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatmentSichen Yuan, Xicheng Yang, Alexa M Bremmer, et al.
Mediators of Inflammation|September 2, 2022
Exosome in Crosstalk between Inflammation and Angiogenesis: A Potential Therapeutic Strategy for StrokeYongdan Cun, Yaju Jin, Danli Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2018
Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomibYulong Xu, Xicheng Yang, Yiyi Chen, et al.
Nature Nanotechnology|May 16, 2025
Engineering pyroptotic vesicles as personalized cancer vaccinesZhaoting Li, Yixin Wang, Fanyi Mo, et al.
European Journal of Medicinal Chemistry|October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activitiesXicheng Yang, Jian Shen, Lulu Jiang, et al.
Nature Communications|December 12, 2025
Dynamically tunable polarized mid-infrared light-emitting diodes from polarization singularities in a band-edge Weyl nodeJunrong Zhang, Fengyuan Xuan, Jiexi Song, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address ConceptLi Xiao, Yujun Wang, Mumei Zhang, et al.
Pageof 2